A Study of Prexasertib (LY2606368) With Chemotherapy or Targeted Agents in Participants With Advanced Cancer

NCT02124148 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

167

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasm Metastasis
Colorectal Neoplasms
Breast Cancer

Interventions

DRUG: Prexasertib
DRUG: Cisplatin
DRUG: Cetuximab
DRUG: G-CSF
DRUG: Pemetrexed
DRUG: Fluorouracil
DRUG: LY3023414
DRUG: Leucovorin

Sponsor

Eli Lilly and Company